Back to search
Regional Citrate Anticoagulation (RCA)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Regional Citrate Anticoagulation (RCA) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Regional Citrate Anticoagulation (RCA) trials you may qualify forPrismocitrate 18 is a continuous renal replacement therapy (CRRT) solution to be used as a renal replacement solution and as an anticoagulant to prevent blood c…
One of the main RRT issues is anticoagulation of the ECC, because blood contact with biomaterials causes bio-incompatibility reactions, including activation of…
The purpose of this research is to determine if an investigational new drug solution called Prismocitrate 18 lengthens extracorporeal circuit life in patients t…
It has been reported in several studies that ionized hypomagnesemia is associated with higher morbidity and mortality rates. During continuous renal replacement…
The purpose of this single center, randomized, control, open-labeled study is to evaluate the effect and safety of RCA versus no anticoagulation for CRRT in hyp…